SARS-CoV-2 Subunit Virus-like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study.
Vakhrusheva AV, Kudriavtsev AV, Kryuchkov NA, Deev RV, Frolova ME, Blagodatskikh KA, Djonovic M, Nedorubov AA, Odintsova E, Ivanov AV, Romanovskaya-Romanko EA, Stukova MA, Isaev AA, Krasilnikov IV.
Vakhrusheva AV, et al. Among authors: romanovskaya romanko ea.
Vaccines (Basel). 2022 Aug 10;10(8):1290. doi: 10.3390/vaccines10081290.
Vaccines (Basel). 2022.
PMID: 36016181
Free PMC article.